Meeting
2017 Gastrointestinal Cancers Symposium
The clinical significance of KRAS monitoring in tumor tissues and blood of patients with pancreatic tumor.
Authors
Fumiaki Watanabe
Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan
Fumiaki Watanabe , Koichi Suzuki , Kosuke Ichida , Yuji Takayama , Taro Fukui , Nao Kakizawa , Hiroshi Noda , Toshiki Rikiyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 334)
DOI
10.1200/JCO.2017.35.4_suppl.334
Abstract #
334
Poster Bd #
F4
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Clinical significance of monitoring KRAS in tissue and serum of pancreatic cancer patients.
First Author: Fumiaki Watanabe
Poster
2020 Gastrointestinal Cancers Symposium
Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients.
First Author: Fumiaki Watanabe
Poster
2016 Gastrointestinal Cancers Symposium
Liquid biopsy leads to a paradigm shift in cancer treatment.
First Author: Koichi Suzuki
Poster
2015 ASCO Annual Meeting
Prognostic value of plasma circulating tumor (ct) DNA KRAS mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients.
First Author: Julia S. Johansen